Journal of Neurosciences in Rural Practice

CASE REPORT
Year
: 2014  |  Volume : 5  |  Issue : 3  |  Page : 258--260

Pleomorphic xanthoastrocytoma in a case of tuberous sclerosis


Arvind G. Martin1, Mutum Samarendra Singh2, Badrisyah Idris1, Jafri Malin Abdullah1,  
1 Department of Neurosciences, Hospital Universiti Sains, Kubang Kerian, Kelantan, Malaysia
2 Department of Pathology, Hospital Universiti Sains, Kubang Kerian, Kelantan, Malaysia

Correspondence Address:
Mutum Samarendra Singh
Department of Pathology, Hospital Universiti Sains, Kubang Kerian, 16150, Kelantan
Malaysia

Abstract

Tuberous sclerosis is a known phakomatosis and the associated finding of a subependymal giant cell astrocytoma is common with this disorder. A case of tuberous sclerosis with a finding not previously reported, i.e. that of a pleomorphic xanthoastrocytoma, is presented here.



How to cite this article:
Martin AG, Singh MS, Idris B, Abdullah JM. Pleomorphic xanthoastrocytoma in a case of tuberous sclerosis.J Neurosci Rural Pract 2014;5:258-260


How to cite this URL:
Martin AG, Singh MS, Idris B, Abdullah JM. Pleomorphic xanthoastrocytoma in a case of tuberous sclerosis. J Neurosci Rural Pract [serial online] 2014 [cited 2017 Nov 21 ];5:258-260
Available from: http://www.ruralneuropractice.com/text.asp?2014/5/3/258/133580


Full Text

 Introduction



Tuberous sclerosis is a known entity being commonly described along with the other phakomatoses with established associations with a particular type of astrocytoma, typically the SEGA variety (subependymal giant cell astrocytoma). Here we present a case of tuberous sclerosis with a finding not previously reported, i.e. that of a pleomorphic xanthoastrocytoma.

 Case Report



A 23-year-old male who was diagnosed with tuberous sclerosis at an early age came to our attention following complaints of blurring of vision for 1 month, associated with nausea, vomiting and headaches. On examination, he was found to be alert with full (GCS) score and bilateral papilledema. His vision was compromised with perception of hand movements noted in both eyes and Shagreen patches were noted over his back.

A CT brain scan was done which revealed a right supratentorial intra-axial lesion which was largely cystic with an enhancing mural nodule as depicted in [Figure 1]. Additionally, midline shift with mild perilesional vasogenic edema were also noted. From the imaging findings, differential diagnoses in this case at this point were subependymal giant cell astrocytoma and pilocytic astrocytoma.{Figure 1}

A craniotomy and a total excision of tumor was performed which was found to be cystic and with minimal solid components. Post-operatively the patient remained alert and symptom free apart from visual compromise. The tumor samples were sent for histopathological examination and were found to be pleomorphic xanthoastrocytoma.

As seen in the [Figure 2]a-d, sections from the wall of the cystic mass showed mildly pleomorphic cells having round to ovoid nuclei with occasional lobulated outline and eosinophilic cytoplasm in a fibrillary background and absent mitotic figures. Scattered lymphocytes and foamy macrophages were noted and hyaline globules and Rosenthal fibers were not seen in this specimen. The tumor cells showed strong positivity for GFAP) and S100 as well.{Figure 2}

 Discussion



Tuberous sclerosis is a known entity being commonly described along with the other phakomatoses and has established associations with a particular type of astrocytoma, typically the SEGA variety. Tuberous sclerosis aka Bournville Disease is a group of autosomal dominant disorders characterized by hamartomas and benign neoplastic lesions that affect the central nervous system and various non-neural tissues. This disorder affects around 25 000 to 40 000 individuals in the United States and about 1-2 million individuals worldwide. [1] Apart from known manifestations seen in the skin, eyes, kidney, heart, digestive system and lung, the central nervous system manifestations of tuberous sclerosis are cortical tubers (freq 90-100%), subependymal nodules (90-100%) and white matter hamartomas and heterotopias (90-100%). The variety of astrocytomas commonly associated with tuberous sclerosis is the SEGA with incidences ranging from 6% to 16%. This findings in this case is unique in that the variant of astrocytoma is hitherto not reported nor described in the current literature, i.e. that of a pleomorphic xanthoastrocytoma.

Pleomorphic xanthoastrocytoma is a rare primary neoplasm of the central nervous system, accounting for only 1% of all astrocytic tumors and was originally described by Kepes et al. in 1979 in his study of 12 cases. [2] This tumor tends to be typically superficially located, supratentorial with a predilection for involving the temporal lobes. It is characteristically seen in young adults who present with intractable seizures, and rendered seizure free post GTR (gross total resection or within 1 year of surgery. [3],[4] Pleomorphic xanthoastrocytomas typically appear as hypointense cystic masses with an enhancing mural nodule on T1-weighted MRI, hyperintense or mixed signal intensity on T2 weighted MRI with suppression of cyst content on FLAIR images. [5] Additionally, Raz et al. also described the peculiar finding of enhancement of the adjacent meninges, which is seen in up to 70% of cases. [5] This tumor is of a low grade subtype, classified under WHO Grade 2 group of gliomas, and although malignant transformation into a higher grade or anaplastic variant is considered rare, histologically this tumor can be confused with Grade IV giant cell glioblastoma due to the findings of giant cells. Pleomorphic xanthoastrocytomas are somewhat uncommon and typically slow-growing, and cases which are completely excised show favorable prognosis.

Classic histopathologic features included an admixture of mononuclear cells, bizarre multinucleated giant cells, spindled cells and lipid-rich vacuolated cells. The tumor cells were associated with abundant lymphocytes and reticulin fibers. They showed little tumor necrosis or mitotic activity. Immunohistochemical study demonstrated diffuse positive staining for glial fibrillary acidic protein, vimentin and S-100 protein. [1],[6],[7] Seventy-seven percent of the cases also showed positive staining for CD34 and it has been suggested that CD34 staining may be used to guide differential diagnoses of these lesions. [8] Mitotic activity has been reported to be uncommon in pleomorphic xanthoastrocytomas and some investigators have highlighted its prognostic significance, as it was the most significant predictor of recurrence and survival. [9] Although surgery, specifically gross total resection, is the treatment of choice, wherein 10 year survival of 70-80% can be expected, currently there is no consensus regarding the role of adjuvant therapy or radiotherapy. [9],[10] It is however interesting to note that the single most significant predictor of recurrence free survival is the extent of resection as reported by Gianni et al. [9] Recurrence free survival was significantly longer in cases who have undergone gross total resection (>80% at 15 years) as compared to subtotal resection (50% at 15 years). [7]

Powell et al. explored the possibility of divergent differentiation in pleomorphic xanthoastroytomas, noting a possible relationship to ganglion cell tumors. [10] The expression of glial and neuronal polypeptides was examined in routinely prepared surgical resections by immunohistochemistry using well-characterized antibodies that recognize GFAP, synaptophysin (SYN), and neurofilament triplet polypeptides (NFPs) in microwave-enhanced single-and double-immunolabeling experiments. Each neoplasm contained cells that were immunoreactive for SYN and/or NFPs, GFAP, and occasionally for both GFAP and either NFP or SYN, and concluded that abortive neuronal/neuroendocrine differentiation may occur in PXAs, suggesting a relationship between PXA and other developmental neoplasms that reveal a more overt neuronal phenotype, such as ganglioglioma, dysembryoplastic neuroepithelial tumor, and desmoplastic ganglioglioma, and with tumors expressing ambiguous glial/neuronal lineage, such as the subependymal giant cell tumor of tuberous sclerosis. Powell et al. also suggested that aberrant expression and accumulation of neuronal intermediate filaments may account for the large, pleomorphic cell morphology observed in many of these tumors. [10]

References

1Louis DN, Ohgaki H, Wiestler OD, Cavanee WK, editors. WHO Diseases of the central nervous system. Lyon: International Agency for Research on Cancer (IARC); 2007.
2Kepes JJ, Rubinstein LJ, Eng LF. Pleomorphic xanthoastrocytoma: A distinctive meningocereberal glioma of young subjects with relatively favorable prognosis. A study of 12 cases. Cancer 1979;44:1839-52.
3Lipper MH, Eberhard DA, Phillips CD, Vezina LG, Cail WS. Pleomorphic xanthoastrocytoma, a distinctive astroglial tumor: Neuroradiologic and pathologic features. AJNR Am J Neuroradiol 1993;14:1397-404.
4Rippe DJ, Boyko OB, Radi M, Worth R, Fuller GN. MRI of temporal lobe pleomorphic xanthoastrocytoma. J Comput Assist Tomogr 1992;16:856-9.
5Raz E, Zagzag D, Saba L, Mannelli L, Di Paulo PL, D'Ambrosio F, et al. Cyst with a mural nodule tumor of the brain. Cancer Imaging 2012;12:237-44.
6Giannini C, Scheithauer BW, Burger PC, Brat DJ, Wollan PC, Lach B, et al. Pleomorphic Xanthoastrocytomas: What do we really know About It? Cancer 1999;85:2033-45.
7Fouladi M, Jenkins J, Burger P, Langston J, Merchant T, Heideman R, et al. Xanthoastrocytoma: Favourable outcome after complete surgical resection. Neuro Oncol 2001;3:184-92.
8Allegranza A, Ferraresi S, Bruzzone M, Giombini S. Pleomorphic Xanthoastrocytoma: Report on four cases-clinical, radiologic and pathologic features. Neurosurg Rev 1991;14:43-9.
9Kros JM, Vecht CJ, Stefanko SZ. Pleomorphic xanthoastrocytoma and its Differential Diagnosis: A Study of Five Cases. Hum Pathol 1991;22:1128-35.
10Powell SZ, Yachnis AT, Rorke LB, Rojiani AM, Eskin TA. Differentiation in pleomorphic xanthoastrocytomas: Evidence for a neuronal element and the possible relationship to ganglion cell tumors. Am J Surg Pathol 1996;20:80-5.